[1]
H. Yanai, H. Adachi, M. Hakoshima, and H. Katsuyama, “The Long-Term Effects of the Selective Inhibitor of Urate Transporter 1, Dotinurad, on Metabolic Parameters and Renal Function in Japanese Patients With Asymptomatic Hyperuricemia”, J Clin Med Res, vol. 17, no. 6, pp. 320–333, Jul. 2025, doi: 10.14740/jocmr6250.